This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Glaxosmithkline LLC. Active years: 2013-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Durham, NC (US) (2013 - 2014)
- Research Triangle Park, NC (US) (2014)
Company Filing History:
Years Active: 2013-2014
Title: Richard Martin Grimes: Innovator in Anti-Viral Compounds
Introduction
Richard Martin Grimes is a notable inventor based in Research Triangle Park, NC (US). He has made significant contributions to the field of chemistry, particularly in the development of anti-viral compounds. With a total of 3 patents, Grimes has focused on creating innovative solutions for treating viral infections.
Latest Patents
Grimes' latest patents include groundbreaking work on chemical compounds. The first patent discloses compounds of Formula I, Formula II, and Formula III. It also covers salts of these compounds, pharmaceutical compositions comprising them, and methods for treating HCV infection through their administration. His second patent focuses on anti-viral compounds, compositions, and methods of use. This patent details compounds, stereoisomers, tautomers, or pharmaceutically acceptable salts, along with their preparation and use for treating infections mediated by viruses in the Flaviviridae family.
Career Highlights
Grimes is currently employed at GlaxoSmithKline LLC, where he continues to advance his research in the pharmaceutical field. His work has been instrumental in developing new treatments that address significant health challenges.
Collaborations
Some of his notable coworkers include Wieslaw Mieczyslaw Kazmierski and Pingyun Chen, who have collaborated with him on various projects.
Conclusion
Richard Martin Grimes exemplifies innovation in the field of anti-viral research, contributing valuable patents that enhance our understanding and treatment of viral infections. His work at GlaxoSmithKline LLC continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile